Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial
Version 2 2024-06-05, 11:18Version 2 2024-06-05, 11:18
Version 1 2014-11-04, 11:34Version 1 2014-11-04, 11:34
journal contribution
posted on 2024-06-05, 11:18authored bySM Rice, IB Hickie, Alison YungAlison Yung, A Mackinnon, Michael BerkMichael Berk, C Davey, DF Hermens, SE Hetrick, AG Parker, MR Schäfer, PD McGorry, GP Amminger
US authorities have recommended 'black-box' warnings for antidepressants because of the increased risk of suicidality for individuals up to age 25. There is thus a clinical and ethical imperative to provide effective treatment for youth depression with an acceptable risk-benefit balance. Long-chain omega-3 polyunsaturated fatty acids (PUFAs) play an important role in a range of physiological processes in living organisms. Supplementation with omega-3 PUFAs has been shown to have a range of beneficial effects on both physical and mental health, and results of previous trials suggest that omega-3 PUFAs may be a safe and effective treatment for depression. However, conclusions from these trials have been limited by their relatively small sample sizes.